Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular toxoplasmosis--clinical aspect.

E Bloch-Michel1

  • 1Hopital de Jour d'Ophtalmologie, Unité d'Immunopathologie Oculaire, C.H.U. De Bicetre, Fac. Med. Paris-Sud, France.

International Ophthalmology
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tear IgE detected by a new method: Stallerdiag-IgE.

Ocular immunology and inflammation·2012
Same author

[Rhinoconjunctivitis: importance of a local diagnosis?].

European annals of allergy and clinical immunology·2004
Same author

Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.

European journal of ophthalmology·2001
Same author

Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.

The British journal of ophthalmology·1999
Same author

Multiple sclerosis associated with uveitis in two large clinic-based series.

Neurology·1999
Same author

Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.

European journal of ophthalmology·1999

Ocular toxoplasmosis presents in three main forms in immunocompetent individuals: pseudo-acquired congenital, congenital in newborns, and acquired toxoplasmosis. Understanding these distinctions is key for accurate diagnosis and treatment.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Parasitology

Background:

  • Ocular toxoplasmosis is a parasitic infection affecting the eye.
  • While often associated with immunocompromised individuals, it also manifests in immunocompetent populations.
  • Understanding the varied presentations is crucial for effective management.

Purpose of the Study:

  • To delineate the distinct clinical aspects of ocular toxoplasmosis in non-immunodeficient individuals.
  • To differentiate between congenital, pseudo-acquired congenital, and acquired forms of the disease.

Main Methods:

  • Review of clinical cases and literature.
  • Analysis of epidemiological and clinical data.
  • Categorization based on age of onset and mode of acquisition.

Related Experiment Videos

Main Results:

  • Ocular toxoplasmosis in immunocompetent individuals presents in three primary forms.
  • These include pseudo-acquired (congenital) forms in adolescents and young adults.
  • Congenital forms in newborns and acquired toxoplasmosis are also significant aspects.

Conclusions:

  • Ocular toxoplasmosis in non-immunodeficient hosts exhibits diverse clinical manifestations.
  • Recognition of these three forms is essential for appropriate diagnostic and therapeutic strategies.
  • Further research into the specific pathogenesis and long-term outcomes of each form is warranted.